Reconstitution of Munc18-Dependent Mast Cell Degranulation by Arnold, Matthew Grant
The University of Southern Mississippi 
The Aquila Digital Community 
Master's Theses 
Summer 8-2016 
Reconstitution of Munc18-Dependent Mast Cell Degranulation 
Matthew Grant Arnold 
University of Southern Mississippi 
Follow this and additional works at: https://aquila.usm.edu/masters_theses 
 Part of the Biochemistry, Biophysics, and Structural Biology Commons, and the Cell Biology Commons 
Recommended Citation 
Arnold, Matthew Grant, "Reconstitution of Munc18-Dependent Mast Cell Degranulation" (2016). Master's 
Theses. 189. 
https://aquila.usm.edu/masters_theses/189 
This Masters Thesis is brought to you for free and open access by The Aquila Digital Community. It has been 
accepted for inclusion in Master's Theses by an authorized administrator of The Aquila Digital Community. For 
more information, please contact Joshua.Cromwell@usm.edu. 
RECONSTITUTION OF MUNC18-DEPENDENT  
MAST CELL DEGRANULATION 
by 
 
Matthew Grant Arnold 
A Thesis 
Submitted to the Graduate School 
and the Department of Biological Sciences 
at The University of Southern Mississippi 
in Partial Fulfillment of the Requirements 
for the Degree of Master of Science 
Approved: 
________________________________________________ 
Dr. Hao Xu, Committee Chair 
Assistant Professor, Biological Sciences 
________________________________________________ 
Dr. YanLin Guo, Committee Member 
Associate Professor, Biological Sciences 
________________________________________________ 
Dr. Vijay Rangachari, Committee Member 
Associate Professor, Chemistry and Biochemistry 
________________________________________________ 
Dr. Karen S. Coats 
Dean of the Graduate School 
 
 
 
August 2016 
  
COPYRIGHT BY 
Matthew Grant Arnold 
2016 
 
Published by the Graduate School  
 
 ii 
ABSTRACT 
RECONSTITUTION OF MUNC18-DEPENDENT 
 MAST CELL DEGRANULATION 
by Matthew Grant Arnold 
August 2016 
Mast cells are specialized secretory leukocytes that play diverse roles in the body, 
mediated by release of histamine and other pharmacologically active substances. 
Although offering essential protection in innate and adaptive immunity, mast cells are 
also essential to the progression of inflammatory diseases, including allergy and asthma,  
(Theoharides et al., 2012). Exocytosis of pro-inflammatory mast cell mediators in 
response to otherwise innocuous antigens relies on evolutionarily-conserved membrane 
fusion machinery. These proteins, called SNAREs, are regulated by the Sec1/Munc18 
(SM) protein family (Lorentz, Baumann, Vitte, & Blank, 2012). Mast cells express three 
mammalian Munc18 isoforms (a, b, and c), which are linked to SNARE-dependent 
exocytosis in numerous organisms. However, the exact roles of each of these Munc18 
isoforms in mast cell degranulation have not been clearly defined.  In this study, we 
investigated the functional relationship between Munc18 and eight sets of degranulation-
relevant SNAREs using in vitro reconstitution. We showed that Munc18a was active in 
stimulating fusion mediated by VAMP2 and VAMP3, but not by VAMP7 and VAMP8. 
In contrast, Munc18b and Munc18c did not show any stimulatory activity. Further 
analysis of Munc18a function unraveled a previously unidentified role in the tethering of 
SNARE complexes prior to fusion, an action that is dependent on the interaction between 
Munc18a and N-peptide of syntaxin. Inhibition of fusion and trans-SNARE complex 
 iii 
formation by soluble VAMP proteins did not interfere with Munc18a-mediated tethering, 
indicating that Munc18a-mediated tethering occurs prior to trans-SNARE complex 
formation. This study therefore sheds light on new roles Munc18 proteins might play to 
regulate mast cell degranulation. 
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CHAPTER I - INTRODUCTION 
Mast cells 
Mast cell origins and subtypes 
First described by Paul Ehrlich in his 1878 dissertation (Ehrlich, 1878), mast cells 
originate from CD34+/c-KIT+/CD13+ progenitor cells in the bone marrow, which migrate 
through the blood into mucosal and connective tissues where maturation occurs (Hallgren 
& Gurish, 2007). This is in contrast to other hematopoietic cell types which mature in the 
bone marrow before being released (Da Silva, Jamur, & Oliver, 2014). The cytokine stem 
cell factor (SCF) produced by fibroblasts is crucial to mast cell maturation, as well as 
their migration into the peripheral tissues (Kirshenbaum et al., 1992; Kirshenbaum, 
Kessler, Goff, & Metcalfe, 1991; Liu, Liu, Li, & Wu, 2010; Okayama & Kawakami, 
2006; Valent et al., 1992). Mice deficient in c-KIT (SCF receptor) completely lack mast 
cells, pointing to c-KIT and SCF as main determinants of mast cell biogenesis in vivo 
(Galli, Tsai, & Wershil, 1993). Other factors such as nerve growth factor (NGF) (Aloe & 
Levi-Montalcini, 1977) and neurotrophin-3 (Lorentz et al., 2007; Metz et al., 2004) are 
also shown to promote mast cell maturation.  However, c-kit remains highly expressed 
throughout the mast cell life cycle, and its interaction with SCF is considered the most 
essential factor in mast cell survival (Kirshenbaum et al., 1999). 
 While SCF serves as the pivotal factor in mast cell differentiation, the local 
environment further directs mast cells into phenotypically distinct subtypes, mucosal 
mast cells (MMCs) and connective tissue mast cells (CTMCs). In rodents, MMCs are 
discernible from CTMCs by their protease contents; MMCs containing only tryptase, 
while CTMCs contain both tryptase and chymase (Church & Levi-Schaffer, 1997). 
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Development of MMCs are dependent on T-cells as shown in studies with athymic nude 
mice (Ruitenberg & Elgersma, 1976), whereas control of CTMC development is poorly 
understood. Expression levels of other mediators also vary among mast cell subtypes, as 
MMCs are seen to secrete less histamine but more Leukotriene C4 than CTMCs (Heavey 
et al., 1988), and human skin mast cells are not seen to express IL-4, 5 or 13 as in other 
masts cells (Gibbs et al., 2001). This distinction is not controlled genetically but rather 
maintained through cross-talk with the environment, as MMCs differentiation into 
CTMCs has been observed (Kitamura, 1989; Welle, 1997). In addition, MMCs have been 
seen to change protease phenotype in vivo, expressing tryptase and chymase in response 
to Trichinella spiralis infection (Friend et al., 1996; Friend et al., 1998). Although useful 
for categorizing mast cell function in the body, classification on location and protease 
content is not  precise as both CTMCs and MMCs are found in lungs, with subtypes 
containing further subtypes of unique expression patterns depending on location 
(Andersson, Mori, Bjermer, Löfdahl, & Erjefält, 2009). Additionally, murine mast cells 
in the trachea express all six serine proteases, further confounding the classic definition 
of mast cell subtypes (Xing, Austen, Gurish, & Jones, 2011). Taken together, the 
functional differences of mast cell subtypes are not thoroughly understood, however it is 
clear that they are amenable to their residential tissue, and the diverse profile of 
mediators could be important to their localization and function. 
Mast cell granules 
The most distinguishing feature of mast cells is the large cytoplasmic granules 
(i.e. secretory lysosomes) which contain a panoply of mediators (Appendix A). The mass 
exocytosis of these granule-stored mediators is termed degranulation, and is commonly 
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observed in activated mast cells during allergic reactions (Amin, 2012). Among these 
histamine is the most well-known, but serotonin and proteases are also major constituents 
(Wernersson & Pejler, 2014). In accordance with the lysosomal-like properties of the 
granules, several lysosomal hydrolases are also present (Wernersson & Pejler, 2014). β-
hexosaminidase is present in virtually all mast cells and therefore its release is frequently 
used as a hallmark for mast  cell degranulation (Fukuishi et al., 2014).  
Although appearing similar in size and staining patterns, granules are 
heterogeneous in their contents. One study with mouse bone marrow-derived mast cells 
(mBMMCs) showed a division between granules containing serotonin and cathepsin D, 
while others contained histamine and TNF (Wernersson & Pejler, 2014).Histamine has 
also been seen to be released independently of β-hexosaminidase(Baram et al., 1999). In 
mouse bone marrow-derived mast cells (BMMCs) at least three types of granules have 
been detected; type I granules containing MHC class II, β-hexosaminidase, LAMP-1, 
LAMP-2 and M6PR, type II containing all of the previously mentioned and serotonin, 
and type III containing only β-hexosaminidase and serotonin (Raposo et al., 1997). It is 
not clear how these distinct granules are differentially regulated for secretion. 
The biogenesis of secretory granule in mast cells is poorly characterized, although 
it is known that granules begin from the trans-Golgi network with the budding of 
clathrin-coated vesicles to form ‘pro-granules’. Fusion of these pro-granules leads to 
larger, immature granules, which will continue V-ATPase-meditated acidification to pH 
~5.5 (Wernersson & Pejler, 2014),  in a fashion similar to lysosomal acidification. A few 
regulators of this biogenesis have been identified, such as secretogranin III (Prasad, 
Yanagihara, Small-Howard, Turner, & Stokes, 2008), Rab5 (Azouz et al., 2014), and 
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synaptotagmin III(Grimberg, Peng, Hammel, & Sagi-Eisenberg, 2003) (Wernersson & 
Pejler, 2014). The mechanism of sorting the vast array of mediators into separate, 
heterogeneous granules is largely unclear, however, it has been reported that histamines, 
proteases, and lysosomal constituents  are transported into granules respectively via 
vesicular monoamine transporter 2 (Wernersson & Pejler, 2014), electrostatic interaction 
with serglycin proteoglycan, and the mannose-6-phosphate dependent vesicular transport 
(Moon, Befus, & Kulka, 2015). 
Mast Cell Pathology and Physiology 
Mast cells in inflammatory disease 
Mast cells are central to inflammatory diseases, especially in allergic reactions 
(i.e. Type I hypersensitivity/immediate hypersensitivity).  According the American 
College of Allergy, Asthma and Immunology, allergic diseases are the 5th largest chronic 
disease in the US in all age groups. In the United States, food allergies in children alone 
are estimated to cost $24.8 billion annually (Gupta et al., 2013). For the past several 
years, food and skin allergies in children have increased for unknown reasons (Jackson, 
Howie, & Akinbami, 2013). Additionally, mast cells contribute to asthma, a chronic 
inflammatory lung disease with recurrent breathing problems (Bradding, Walls, & 
Holgate, 2006). The Centers for Disease Control and Prevention estimates that asthma 
affects 25 million people and cost the United States $56 billion in 2007 ().  
Aside from allergies and asthma, mast cells also contribute to other common 
inflammatory diseases such as type IV hypersensitivity (delayed hypersensitivity) 
(Biedermann et al., 2000), arthritis, atopic dermatitis, psoriasis, and multiple sclerosis 
(Theoharides et al., 2012). Rare diseases such as mastocytosis and mast cell activation 
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syndrome (MCAS), where patients have an abnormal increase in mast cell number or a 
hyper-responsive mast cell population, lead to  susceptibility to idiopathic anaphylactic 
shock (Metcalfe, 2008). Understanding mast cell secretion is therefore essential to 
developing therapeutic strategies in treatment and prevention of inflammatory diseases. 
The numerous vasoactive and proinflammatory mediators released by mast cells 
fall into two categories, the immediately releasable, pre-formed mediators stored in 
secretory granules such as histamine, serotonin, TNF, kinins and proteases, and the de 
novo synthesized mediators upon mast cell activation. Among the latter are leukotrienes, 
prostaglandins, and platelet-activating factor, which are synthesized from arachidonic 
acid liberated by phospholipases. Numerous cytokines are also synthesized de novo after 
activation, including IL-1, 2, 5, 6, 8, 9, 13 and vascular endothelial growth factor (VEGF) 
(Theoharides et al., 2012). Release of these mediators has shown to induce recruitment of 
mast cell progenitors to sites of inflammation in the lungs. These progenitors, in turn, will 
release their own mediators, perpetuating the cycle of inflammation (Ikeda et al., 2003).  
Most mediators released influence inflammation by acting on cell receptors 
causing vasodilation, bronchoconstriction, immune cell chemotaxis, and/or itching 
sensation(reviewed in (Jutel, Akdis, & Akdis, 2009; Leurs, Smit, & Timmerman, 1995)). 
However, mast cell proteases play a unique dual role in regulating inflammation. In 
promoting inflammation, mast cell proteases can digest plasma albumin to liberate 
histamine-releasing peptides, stimulating mast cell degranulation and perpetuating the 
inflammatory process (Cochrane, Carraway, Miller, Feldberg, & Bernheim, 2003). 
mMCP-6 (tryptase)has shown importance in progressing allergic asthma in mice (Cui et 
al., 2014), perhaps due to the fact that serine proteases such as tryptase and chymase also 
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act on protease-activated receptors and cause further inflammation (Schechter, Brass, 
Lavker, & Jensen, 1998). These same proteases can also help prevent inflammation. 
Mouse mast cell protease 6 (mMCP-6) digests IL-6, a pro-inflammatory cytokine that is 
generally elevated during allograft rejection. Localized IL-6 reduction by MCP-6 is 
necessary for allograft tolerance (de Vries, Elgueta, Lee, & Noelle, 2010). Similarly, 
another protease, mMCP-4 degrades IL-33 and is protective in an allergic lung 
inflammation model (Waern et al., 2009; Waern, Lundequist, Pejler, & Wernersson, 
2013). β-tryptase limits allergic inflammation by targeting IgE molecules after 
degranulation (Rauter et al., 2008). Since proteases represent 25% of mast cell protein 
content, they underscore a significant portion of mast cell activity (Da Silva et al., 2014). 
Physiological roles of mast cells 
Understandably, mast cells have become synonymous with inflammatory disease, 
however they also play beneficial roles in innate and adaptive immune responses, 
resistance to toxins, tissue repair and angiogenesis (Palker, Dong, & Leitner, 2010). Their 
widespread peripheral location ideally situates them as a first line of defense in regulating 
immune function. These functions are poorly characterized in comparison to mast cells in 
allergic disease, but are seemingly essential as no humans lacking mast cells have been 
described so far (Palker et al., 2010). The same mediators that cause inflammation act in 
normal mast cell function. 
Mast cells are among the first cells to recognize antigens in the body. The variety 
of receptors such as Toll-like receptors (TLRs), nucleotide-binding oligomerization 
domain (NOD)-like receptors (NLRs), retinoic acid-inducible (RIG)-I-like receptors 
(RLRs) and complement receptors allow general recognition of foreign particles (Da 
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Silva et al., 2014). Interaction with these receptors causes mast cell activation, which can 
lead to a variety of responses dependent on the ligand. Degranulation of pro-
inflammatory mediators and cytokine/chemokine production is common for clearance of 
bacterial, viral and parasitic infection and upregulation of immune response (Da Silva et 
al., 2014).  
Mast cells can clear bacterial infections through either phagocytic activity or 
production of potent antimicrobials such as cathelicidin LL-37, β-defensins and piscidins 
(Silphaduang & Noga, 2001) (in fish MCs) when they are stimulated by various 
pathogens. Release of β- hexosaminidase has shown protection against bacterial 
infection, possibly through targeting of cell wall peptidoglycan (Fukuishi et al., 2014). 
Additionally, production of mast cell extracellular traps (MCETs), similar to neutrophils 
(called NETs),concentrate certain antimicrobial products such as cathepsin G and 
cathelicidin LL-37 and may act as a physical barrier for infection (Brinkmann et al., 
2004; Thomas et al., 2014; von Köckritz-Blickwede et al., 2008). Production of 
chemokines will attract nearby immune cells such as eosinophils (IL-33, eotaxin/CCL11), 
natural killer cells (IL-8), and neutrophils (CXCL1/CXCL2, TNFα, LTB4, LTC4, and 
MCP-6), Th cells (IL-33) and basophils (IL-33) to sites of infection (Da Silva et al., 
2014; Hsu, Neilsen, & Bryce, 2010). In particular, release of pre-stored TNFα has shown 
antibacterial protection against mast cell-deficient mice through neutrophil chemotaxis 
(Malaviya, Ikeda, Ross, & Abraham, 1996). Mast cells have also been shown to be 
activated by snake venom, which gets degraded subsequently by proteases (Theoharides 
et al., 2012). 
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Mast cells mediators coordinate the adaptive immune response through 
interactions with dendritic cells and T cells and direct their migration to lymph nodes 
(Galli, Nakae, & Tsai, 2005; Theoharides et al., 2012). Certain mast cell subtypes highly 
expressing FcεRI and MHCII can function as antigen-presenting cells (Theoharides et al., 
2012). Mast cells interact with T cells and superactivate them through TNF. In turn, T 
cells can activate mast cell degranulation and IL-8 release (Theoharides et al., 2012). 
Less is known about mast cells in viral infection, although they have shown secretion of 
anti-inflammatory cytokines such as IL-10 and TGF-β limit the magnitude of immune 
responses (Da Silva et al., 2014). production of IFN-1 initiates immune responses to viral 
infection (Da Silva et al., 2014). 
Mast cells are also crucial for the repair of damaged tissues through several 
distinct pathways. Mediators such as nerve growth factor (NGF), platelet-derived growth 
factor (PDGF), vascular endothelial growth factor (VEGF), fibroblast growth factor-2, 
histamine and tryptase induce epithelial and fibroblast proliferation. PAF, leukotrienes, 
IL-1 and IL-8 from mast cells can activate platelet aggregation to seal injured areas. 
Secretion of heparin, tryptase and t-plasminogen activator regulate fibrolytic mechanisms 
providing appropriate perfusion and nutrition necessary for repair. Released mast cell 
mediators also cause chemotaxis of leukocytes, which will clear infection from the area. 
Mast cells then stimulate proliferation of endothelial cells, fibroblasts and keratinocytes 
allowing angiogenesis, generation of new extracellular matrix, and wound contraction 
(Da Silva et al., 2014). 
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Mast cell activation 
Mast cells can be activated by a variety of stimuli and release distinct patterns of 
mediators, dependent on the type and intensity of the stimuli (Hsu et al., 2010). Allergen-
induced IgE-receptor-mediated degranulation is most recognized and best studied. In 
contrast, receptors for cytokines and pathogen-associated molecular patterns (PAMPs) 
underscore a different type of response that sometimes lacks the characteristic of classical 
degranulation.  
IgE-mediated degranulation. Allergen-induced mast cell activation triggers three 
processes: 1) degranulation of prestored mediators, 2) lipid metabolism for leukotriene 
production, and 3) transcription factor activation for de novo synthesis of cytokines. 
Initiation of the allergic reaction begins with surface receptor FcεRI, bound with IgE, 
aggregating through interaction with a multivalent antigen. Mast cells constitutively 
express the high-affinity IgE receptor FcεRI, as binding monomeric IgE is known to 
induce pro-survival signals in the cell (Kalesnikoff et al., 2001). Due to the normally low 
serum concentrations of IgE, the high affinity FcεRI is needed for efficient recruitment of 
these molecules. This receptor is also highly expressed in basophils but minimally 
expressed in eosinophils, Langerhans cells, monocytes, and platelets (Owen, Punt, 
Stranford, & Jones, 2013). 
The FcεRI receptor is a heterotetramer consisting of a single α and β chain, and 
two disulfide-linked γ chains. The α chain contains two N-terminal domains that are 
homologous with immunoglobulin-fold structures, thus binding extracellular IgE, while 
the β and γ polypeptides contain intracellular ITAMs (immunoreceptor tyrosine-based 
activation motifs) responsible for the initiation of signaling pathways. The FcεRI 
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complex is located on lipid rafts, a region typically devoid of transmembrane 
phosphatases (Simons & Toomre, 2000). Aggregation of IgE-FcεRI through multivalent 
antigen excludes phosphatases, allowing phospho-signaling to occur. 
To begin the signaling cascade, Src-family kinases (Lyn, Fyn, and Syk) 
phosphorylate ITAMs located on FcεRI subunits. Phosphorylated ITAMs allow 
recruitment and activation of additional Src-family kinases through SH2 domains. 
Activated kinases subsequently phosphorylate ITAMs of adaptor proteins LAT and 
NTAL, which serve as platforms for recruitment of various proteins(Rivera & Gilfillan, 
2006). 
 
Figure 1. IgE-mediated signaling pathway in mast cells. 
Simplified diagram showing IgE-mediated signal pathway in mast cells. Original picture obtained from Rivera et al., 2006 (Rivera & 
Gilfillan, 2006) 
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LAT will recruit phospholipase C to create IP3 and DAG to increase intracellular 
calcium and activate protein kinase C (PKC). NTAL activates PI3K, also contributing to 
calcium mobilization. Calcium release will stimulate degranulation of prestored 
mediators through binding to calcium sensing synaptotagmin II found on granule 
membranes (Baram et al., 1999). PKC activation stimulates the MAPK pathway, leading 
to cytokine production and leukotriene production (Rivera & Gilfillan, 2006). PKC has 
been shown to phosphorylate proteins associated with membrane fusion on granules, 
though it is currently unknown if this occurs in mast cells as well (Genç, Kochubey, 
Toonen, Verhage, & Schneggenburger, 2014). 
Allergen-independent activation. Allergens are not the only method for inducing 
mast cell response. A variety of systems are used to modulate mediator release, 
sometimes without the characteristic degranulation. Their strategic distribution 
throughout the body and various physiological functions require their recognition of 
different signals coupled with appropriate mediator release or production. The majority of 
allergen-independent mechanisms are involved in mast cell immune function. 
Accordingly, mast cells recognize pathogens through common molecular motifs through 
TLRs, NLRs, and RLRs.  
Activation through TLRs can selectively regulate mast cell mediator release. 
Studies with murine mast cells have shown expression of TLR 1-4 and 6-9, while human 
mast cells have expressed TLR1-7, 9 and 10 with a great degree of variation (reviewed in 
(Sandig & Bulfone-Paus, 2012)). Interaction of TLR 4 with LPS induces TNFα, IL-5, 10, 
and 13 production without inducing degranulation. TLR 3, 7, 9 activation have seen TNF, 
IFN and IL-6 production, also without degranulation (Theoharides et al., 2012). TLR 9 
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activation induces to IL-6 production, but again is not observed to affect degranulation 
(Ikeda et al., 2003). On the other hand, TLR 2 with staphylococcal peptidoglycan has 
seen induction of degranulation and histamine release. In some studies peptidoglycan 
and/or LPS have induced mast cell migration through unknown mechanisms. There is a 
high degree of variability in mast cell response to TLR ligands, due to differences in 
species and origin of the cell types. It can be appreciated that mast cells have different 
responses to antigens in context of their natural microenvironment.   
Complement fragment C3a in the presence of aggregated IgG has shown 
increased degranulation. Free immunoglobulin light chains have shown to mediate 
hypersensitivity-like reactions. Anti-microbial β-defensins have been shown to activate 
mast cells (Theoharides et al., 2012). Mast cells are also observed to degranulate in 
response to complement fragments, neuropeptides (such as substance P), and certain 
toxins (Wernersson & Pejler, 2014). Mast cells mediators also in turn regulate 
degranulation. Promotion of degranulation is seen through release of corticotropin-
releasing hormone, neurotensin, reactive oxygen species, stem cell factor, substance P, 
tryptase, thymic stromal lymphopoietin and IL-1, 9 and 33. Osteopontin is also seen to 
augment IgE-mediated degranulation (Nagasaka et al., 2008). Inhibitors of degranulation 
are chondroitin, heparin, IL-10, nitric oxide, TGFβ, and UCP2 (Theoharides et al., 2012). 
SNARE-mediated Mast Cell Exocytosis 
SNARE proteins are the key components to membrane fusion events and 
intracellular trafficking in eukaryotic cells. The transfer of newly synthesized proteins in 
vesicles to membrane-bound compartments requires unification of the lipid bilayers to 
allow delivery of vesicle contents to the target localization. This process is mediated in a 
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large part by SNARE proteins through formation of a trans-SNARE complex between 
the apposing membrane bilayers. SNARE proteins overcome the repulsive forces 
between lipid bilayers and allow selective recognition of different compartments through 
SNARE pairing. To distinguish one compartment from another, a variety of SNARE 
proteins are expressed which fall under families of Q-SNAREs and R-SNAREs. Crystal 
structure data from the SNARE complexes shows a characteristic central ionic layer (i.e. 
zero layer) consisting of the side chains of  an arginine (R) and three glutamine (Q) 
residues (Fasshauer, Sutton, Brunger, & Jahn, 1998). SNARE proteins contributing a 
glutamine or an arginine to the SNARE complex are termed Q-SNAREs or R-SNAREs, 
respectively. In exocytosis the common Q-SNAREs are isoforms of syntaxins and SNAP-
25, while R-SNAREs are usually VAMP isoforms. The trans-SNARE complex consists 
of a four helical coiled-coil bundle. SNARE complexes forming at the plasma membrane 
typically contain a single helix each from syntaxin and VAMP, and two helices from a 
SNAP-25-like protein (reviewed in (McNew, 2008)). Each of these helices contain a 60-
70 aa SNARE motif that combine to form the highly stable tetrameric structure that is 
required for membrane fusion (Sutton, Fasshauer, Jahn, & Brunger, 1998). For the most 
part, SNARE proteins are anchored to their respective membranes through a C-terminal 
transmembrane domain. SNAP-25-like molecules, however, do not have a 
transmembrane domain but instead are anchored through palmitoylation of several 
cysteines (Fukasawa, Varlamov, Eng, Söllner, & Rothman, 2004). Additionally, several 
syntaxin family proteins have N-terminal regulatory regions termed the Habc region. This 
three-helical region folds back onto the SNARE motif of the protein, creating a ‘closed 
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conformation’ that prevents assembly of the SNARE complex. Syntaxin must adopt an 
open conformation in order for fusion to occur.  
Munc18 proteins 
SNARE proteins constitute the minimal requirement for membrane fusion, 
however in vitro these interactions have been shown to be highly promiscuous and non-
selective (Izawa, Onoue, Furukawa, & Mima, 2012). There are several accessory proteins 
known to regulate SNARE interactions, perhaps most important is the multi-functional 
Sec1-Munc18 (SM) protein family(reviewed in (Hong & Lev, 2014)). Different SM 
proteins are required for maintaining specificity in fusion reactions through the cell at 
different localizations. The Munc18 proteins coordinate membrane fusion reactions at the 
plasma membrane, including neurotransmitter release in neurons, insulin-regulated 
GLUT4 translocation, and mast cell degranulation. Munc18 proteins play vital roles for 
the cell, Munc18a deletion in mice causes complete paralysis and death soon after birth 
(Verhage et al., 2000), mutations in Munc18b cause life-threatening immunodeficiencies 
in natural killer and cytotoxic T cells (Spessott et al., 2015), and Munc18c deletion in 
mice results in death in utero or within 6 hours after birth (Kanda et al., 2005). 
Due to its importance in neurotransmission, Munc18a is the most studied, and 
conclusions regarding the function and mechanism of SM proteins are based heavily on 
Munc18a. Munc18 proteins are thought to play three distinct roles in modulating 
intracellular trafficking: 1) chaperoning plasmalemmal syntaxins through the cell to the 
plasma membrane in a closed conformation, 2) activating specific trans-SNARE 
complexes for fusion and 3) docking of large dense-core vesicles to the plasma 
membrane (Han et al., 2009). Binary interactions between Munc18 and syntaxin proteins 
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are thought to prevent assembly of the trans-SNARE complex, thus playing an inhibitory 
role in fusion, while binding to the trans-SNARE complex accelerates membrane fusion. 
Munc18 proteins have two binding modes responsible for these distinct functions. Mode 
1 is the binary interaction with the syntaxin protein in closed conformation; whereas 
Mode 2 stimulates the trans-SNARE complex and relies on a ‘hydrophobic pocket’ of 
Munc18 to bind the syntaxin N-terminal peptide, with additional contacts made with the 
VAMP protein in the complex. Munc18 stimulation of the trans-SNARE complex has 
been shown to be largely VAMP-dependent, and syntaxin-independent as the N-terminal 
peptide bears little selectivity for Munc18 recruitment among syntaxin isoforms (Hu et 
al., 2011). Transition between Munc18 binding modes is suggested to be regulated by the 
Munc13 proteins and post-translational modifications (Aran, Bryant, & Gould, 2011; 
Barclay et al., 2003; Liu et al., 2007; Ma, Li, Xu, & Rizo, 2011). 
Membrane fusion machinery in mast cells 
Mast cells express a variety of SNARE proteins, although their significance in 
degranulation is still under debate. Q-SNARE syntaxin3 is localized to secretory granules 
(Hibi, Hirashima, & Nakanishi, 2000; Tadokoro, Kurimoto, Nakanishi, & Hirashima, 
2007), while syntaxin4 and SNAP-23 localize to the plasma membrane (Guo, Turner, & 
Castle, 1998; Tadokoro et al., 2007). R-SNAREs VAMP2, 3, 7 and 8 are localized on 
different vesicles in the cytoplasm. VAMP2 and VAMP3 have been shown to co-localize 
with small vesicles and multi-vesicular bodies (Paumet et al., 2000; Tiwari et al., 2008), 
while VAMP7 and VAMP8 localize to the larger vesicles, containing histamine and β-
hexosaminidase, respectively (Puri & Roche, 2008; Sander et al., 2008). While most 
studies show that VAMP8 and syntaxin4 are the major SNAREs in mast cell 
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degranulation (Paumet et al., 2000), it is highly likely that  the other SNAREs are 
involved. As stated earlier, mast cell granules are heterogeneous in their contents, thus 
studies utilizing a single marker for degranulation are most likely overlooking evidence. 
The abundance of possible exocytic SNARE complexes could be important in allowing 
selective mediator release following mast cell activation. 
Mast cells also express all three mammalian isoforms of Munc18 (Nigam et al., 
2005), which could have different specificities in SNARE interactions (Yu et al., 2013). 
Munc18b is shown to be the dominant isoform expressed in both bone marrow-derived 
mast cells (BMMCs) and rat basophilic leukemia cells (RBL-2H3), comprising 64% of 
the Munc18 isoforms; while Munc18a and Munc18c are less abundant with 21% and 
15%, respectively (Nigam et al., 2005). Both Munc18a and Munc18b have been shown to 
regulate degranulation in RBL-2H3 cells (Bin, Jung, Piggott, & Sugita, 2013). 
Hydrophobic pocket mutations  in Munc18a/b effectively inhibit degranulation as much 
as knock-down mutants implicating binding Mode 2 and stimulation of the trans-SNARE 
complex as the primary function of Munc18 isoforms in mast cell degranulation (Bin et 
al., 2013). Surprisingly, overexpression of either wild-type Munc18a or Munc18b 
efficiently rescued degranulation in double-knockdown mutants, suggesting redundancy 
in either the Munc18 proteins or the SNARE proteins on granules (Bin et al., 2013). Little 
is known about the role of Munc18c in mast cells, however overexpression has shown no 
difference in externalization of phosphatidylserine found on secretory lysosomes (Martin-
Verdeaux et al., 2003).  
While Munc18-mediated stimulation of trans-SNARE complexes may be 
essential for mast cell degranulation, there is no indication of which SNARE-complexes 
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are being recognized by Munc18 proteins. Additionally, there is very little known about 
the binary interactions between Munc18 and syntaxin isoforms in mast cells (Binding 
Mode 1). Munc18b has been shown to interact with syntaxin3 and not syntaxin4 
(Tadokoro et al., 2007), and Munc18c with only syntaxin4 (Martin-Verdeaux et al., 
2003). It is unknown whether Munc18a interacts with either in mast cells. It is unclear 
whether the syntaxin N-terminal peptide plays a role in the binding of different Munc18 
isoforms, as well as whether or not Munc18 binding to these syntaxins causes inhibition 
of trans-SNARE complex formation. 
Specific Aims 
Due to the heterogeneous nature of mast cells and their granules, and the 
abundance of possible SNARE complexes mediating fusion it is difficult to assess the 
functional interaction between Munc18 isoforms and exocytic SNAREs directly during 
mast cell exocytosis.  A powerful alternative is to studying their property in 
reconstitution, comparing their functional (stimulation of various SNARE-mediated 
fusion reactions (as shown in Figure 2), promoting trans-SNARE complex formation, 
etc) and their biochemical activities (interaction with syntaxin proteins). These studies 
aim to determine the relevance of each Munc18 isoform in mast cell exocytosis and 
which SNARE-complex interactions take place. The results from the studies will present 
a more clearly defined picture of how Munc18 proteins regulate mast cell exocytosis, 
which will facilitate future identification of targeted drug therapies for control of mast 
cell pathology, perhaps without major affects to normal physiological function.  
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Figure 2. Illustration of RPL Fusion Assay 
Donor RPLs contain fluorescence-labeled lipids where NBD fluorescence is quenched by Rhodamine. SNARE-medaited fusion of 
Donor with Acceptor RPLs (non-fluorescently-labeled) allows dilution and detection of NBD fluorescence. 
Central Hypothesis: Munc18 isoforms differentially regulate mast cell exocytosis through 
interactions with isoform-specific SNARE complexes. 
Aim 1: Determine fusogenic SNARE complexes present in mast cells. 
Aim 2: Determine selective stimulation of various SNARE complexes by different Munc18 
isoforms. 
Aim 3: Investigate role of Munc18 proteins in events preceding the final membrane 
fusion. 
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CHAPTER II – MATERIALS AND METHODS 
Expression and Purification of Recombinant Proteins 
SNARE proteins for proteoliposome preparation 
All constructs for recombinant SNARE expression were made using cDNA 
templates from Rattus norvegicus unless otherwise noted. Genes encoding VAMP2, 3 
and 8, syntaxin3, syntaxin4 and SNAP-23 were inserted into the pMBP-parallel1 vector 
(Sheffield, Garrard, & Derewenda, 1999) using NcoI and EcoRI restriction sites for an N-
terminal, TEV-cleavable MBP tag. Alternatively, VAMP7 was cloned into pET MBP 
His6 vector using the LIC v3 tag sites, and expressed with a C-terminal, TEV-cleavable 
MBP tag. Wildtype syntaxin3 and syntaxin4 were similarly cloned into pET MBP to 
generate produce native N-termini on recombinant proteins. Syntaxin3ΔN aa28-289 (as 
previously described in (Peng, Guetg, Abellan, & Fussenegger, 2010)) and syntaxin4ΔN 
aa37-298 (as previously described in (Aran et al., 2009)) were cloned into pET MBP 
vector using respective primers with the addition of methionine at the N-terminus. pET 
MBP His6 LIC cloning vector (2Cc-T) was a kind gift from Scott Gradia (Addgene 
plasmid # 37237).  
Proteins were expressed using E. coli expression strains Rosetta2 for pMBP 
expression vectors or Rosetta2(DE3) for pET MBP expression vectors. Cells for protein 
expression were induced at OD600 = 1.00 with 0.5 mM IPTG and grown in 1 L Terrific 
Broth at 37°C for 4 hr. Collected cell pellets were resuspended in 20mL Buffer A 
containing 50 mM HEPES-KOH, pH 7.5, 500 mM KCl, 10% Glycerol, 1 mM DTT 
supplemented with 5 mM Benzamide, 1 mM PMSF and Protease Inhibitor Cocktail 
(0.62mg/mL leupeptin, 4mg/mL pepstatin A, and 24.4mg/mL pefabloc-SC). Cells were lysed 
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through French Press at 900 psi twice. For syntaxin3 and syntaxin4 purification, lysates 
were co-incubated with 40 mM CHAPS for 1hr at 4°C, while for VAMP purification, 
lysates were co-incubated with 100 mM β-octoglucoside. Proteins were purified with 5 
mL Amylose Resin (New England Biolabs) pre-equilibrated with Buffer A supplemented 
with the respective detergent. Resin-bound protein and then washed with 20 mL of Buffer 
A containing respective detergent and eluted with the addition of 10mM Maltose to 
detergent-containing Buffer A. Protein concentrations were determined by standard 
Bradford assay before elutes were frozen in liquid N2 and stored at -70°C. 
Table 1  
Primers used for cloning 
Primer Sequence Vector 
5’ Munc18a EcoRI CGGAATTCATGGCCCCCATTGGCC pMBP-parallel1 
N-terminal MBP tag 3’ Munc18a SalI ACGCGTCGACTTAACTGCTTATTTCTTCGTCTG 
5’ Munc18b BamHI ATGGGATCCATGGCGCCCTTGGGGC pFastBac B 
N-terminal His6 tag 3’ Munc18b SalI ACGCGTCGACTCAGGGCAGGGCTATGTCCTC 
5’ VAMP3 NcoI AAACCATGGGCATGTCTACAGGGGTGCCTTC pMBP-parallel1 
N-terminal MBP tag 3’ VAMP3 EcoRI GCGAATTCTTAAGAGACACACCACACAATG 
5’ VAMP2 NcoI TGCCATGGGAATGTCGGCTACCGCTGC pMBP-parallel1 
N-terminal MBP tag 3’ VAMP2CD EcoRI GCGAATTCTTACTTGAGGTTTTTCCACC 
5’ VAMP8 NcoI TGCCATGGAGGCCAGTGGGAG pMBP-parallel1 
N-terminal MBP tag 3’ VAMP8CD EcoRI GCGAATTCTTACATCTTCACATTCTTCCACC 
5’ Syntaxin3 LIC v3 TTTAAGAAGGAGATATAGTTCATGAAGGACCGACTGGAG 
pET MBP His6 LIC 
C-terminal MBP/His6 tag 
3’ Syntaxin3 LIC v3 GGATTGGAAGTAGAGGTTCTCTTTCAGCCCAACGGAC 
5’ Syntaxin3ΔN LIC v3 TTTAAGAAGGAGATATAGTTCATGAATACAGCGTTCATGGATGAG 
5’ Syntaxin4 LIC v3 TTTAAGAAGGAGATATAGTTCATGCGCGACAGGACC 
pET MBP His6 LIC 
C-terminal MBP/His6 tag 
3’ Syntaxin4 LIC v3 GGATTGGAAGTAGAGGTTCTCTCCAACGGTTATGGTGATG 
5’ Syntaxin4ΔN LIC v3 TTTAAGAAGGAGATATAGTTCATGCCGGACGACGAGTTCTTCCAG 
 
VAMP cytoplasmic domains 
Constructs of recombinant VAMP2 and VAMP8 cytoplasmic domains (CD) were 
generated omitting the C-terminal transmembrane domain, expressing VAMP2 aa1-94 
(as previously described in (Poirier et al., 1998)) and VAMP8 aa1-75 as determined by 
the TMpred program (Hofmann & Stoffel, 1993) and annotations found in NCBI. 
Cloning and protein purification were performed in the same way as full-length proteins 
 21 
(above), except detergents were omitted during the purification process. MBP-VAMP 
CDs were subsequently dialyzed into RB150 (20mM HEPES-NaOH, pH 7.4, 150mM 
NaCl, 10% Glycerol) prior to snap-freezing in liquid N2 and storage at -70°C. 
Munc18 proteins 
cDNA encoding rat Munc18a and Munc18c were obtained from 
ThermoScientific, while Munc18b template was generously provided by T. Südhof. 
Templates were amplified with respective primers listed in Table1 and cloned into 
pMBP-parallel1 using EcoRI and SalI restriction sites. Munc18a was expressed using E. 
coli Rosetta2 induced at OD600 = 1.00 with 0.2 mM IPTG, and grown in 1 L Terrific 
Broth at 22°C overnight. Cell pellets were resuspended in 20 mL buffer B containing 50 
mM Tris-Cl, pH 8.0, 500 mM KCl and 5 mM EDTA supplemented with 5 mM 
Benzamidine, 1 mM PMSF and Protease Inhibitor Cocktail. Purification via Amylose 
Resin proceeded as stated for VAMP CD purification. Eluted MBP-Munc18a was 
dialyzed into RB150 prior to snap-freezing in liquid N2 and storage at -70°C. 
For binding assays, His6-Munc18a was expressed from plasmid pPROEX-HTb-
rMunc18a, a kind gift from Axel Brunger (Zhang et al., 2015) in Rosetta2(DE3). 
Rosetta2(DE3)/pPROEX -HTb-rMunc18a cells were grown in 1 L Terrific Broth at 37°C 
to an OD600= 1.2, where expression was induced with 0.5 mM IPTG. Cultures were then 
incubated for 4 hr at 37°C before cell pellets were harvested by centrifugation and 
resuspended in 20 mL of Buffer C (50 mM HEPES-KOH, pH 7.5, 500 mM KCl, 10% 
glycerol, 1 mM DTT) containing 10 mM imidazole, 1 mM PMSF, and 1x PIC.  
Following French Press at 900 psi, 1% TritonX-100 was added to the lysate for 30 min at 
4°C and lysates clarified by ultracentrifugation with a Beckman Type 70 Ti rotor (4 °C, 
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30 min, 18,500 rpm).  The supernatants were applied to 4 mL of Ni-NTA resin (Qiagen) 
pre-equilibrated with Buffer C, and nutated for 2 hr at 4°C.  Resins were then washed 
with 20 mL of respective buffers containing 50 mM imidazole, followed by protein 
elution in 20 mL of respective buffers containing 300 mM imidazole. His6-Munc18a was 
dialyzed 1,000,000-fold in RB150 overnight at 4°C, concentrated using 30k MWCO 
Microsep™ Advanced Centrifugal Device, snap-frozen in small aliquots in liquid N2, and 
stored at – 70°C.   Protein concentration was determined by the standard Bradford assay. 
Purifications of MBP-tagged Munc18b and Munc18c were attempted similarly to 
Munc18a but did not yield soluble proteins. As an alternative, Munc18c (mouse) was 
expressed from pFastBac-HT-JS-Munc18c (a kind gift from Dr. Jingshi Shen), then were 
expressed in Sf9 insect cell line (gift from Dr. Fengwei Bai; in collaboration with Dr. Hao 
Xu). Likewise, Munc18b (rat) template was amplified by PCR and inserted into 
pFastBac-HT-JS (gift from Dr. Jingshi Shen) and expressed utilizing Sf9 expression 
system. Recombinant proteins were purified using Ni-NTA resin from the lysates of 
transfected Sf9 cells according to established protocols (Xu, Arnold, & Kumar, 2015). In 
brief, Buffer C containing protease inhibitors and 20 mM imidazole was used to 
resuspend the cell pellet, after which 1% TritonX-100 was added.  Following a 30 min 
incubation at 4°C, the lysates were homogenized with Dounce homogenizer (20 times), 
and then clarified by ultracentrifugation with a Beckman Type 70 Ti rotor (4 °C, 30 min, 
18,500 rpm).  The supernatants were applied to 4 mL of Ni-NTA resin (Qiagen) pre-
equilibrated with Buffer C containing 10 mM imidazole, and nutated for 2 hr at 4°C.  
Resins were then washed with 20 mL of respective buffers containing 20 mM imidazole, 
followed by protein elution in 20 mL of respective buffers containing 200 mM imidazole. 
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Recombinant proteins were dialyzed 1,000,000-fold in RB150 overnight at 4°C, 
concentrated using 30k MWCO Microsep™ Advanced Centrifugal Device, snap-frozen 
in small aliquots in liquid N2, and stored at – 70°C.   Protein concentrations were 
determined by the standard Bradford assay. 
Reconstituted Proteoliposome Preparation 
Fluorescent lipids were obtained from Invitrogen. Non-fluorescent lipids were 
from Avanti Polar Lipids, Inc. Donor proteoliposomes contain 60% POPC (1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphocholine), 17% POPE (1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoethanolamine), 10% DOPS (1,2-dioleoyl-sn-glycero-3-phosphoserine), 10% 
cholesterol, 1.5% NBD-DHPE [N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)-1,2-
Dihexadecanoyl-sn-Glycero-3-Phosphoethanolamine], and 1.5% rhodamine 
DHPE(Lissamine™ Rhodamine B 1,2-Dihexadecanoyl-sn-Glycero-3-
Phosphoethanolamine), whereas acceptor proteoliposomes contain 60% POPC, 19% 
POPE, 10% DOPS, 10% cholesterol and 1% Dansyl DHPE [N-(5-
Dimethylaminonaphthalene-1-Sulfonyl)-1,2-Dihexadecanoyl-sn-Glycero-3-
Phosphoethanolamine].  Proteoliposomes were prepared under N2 gas to prevent lipid 
oxidation. Lipid films and proteins were resuspended in RB500 with 40mM CHAPs and 
subsequently dialyzed into RB150 overnight. RPLs (reconstituted proteoliposomes) were 
then harvested through flotation in a Histodenz density gradient as previously described 
(Shen, Tareste, Paumet, Rothman, & Melia, 2007). SNARE proteins were kept at similar 
densities as reconstitution studies of neuronal transmission (Hickey & Wickner, 2010; 
Ma et al., 2011; Shen et al., 2007), with protein: lipid ratios at or below 1:200 for R-
SNARE bearing donor RPLs and at or below 1:500 for Q-SNARE bearing acceptor 
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RPLs. Concentrations of harvested RPLs were determined by quantification of Dansyl-
DHPE or Rhodamine on acceptor and donor RPLs, respectively (Hickey & Wickner, 
2010). RPLs were stored in 10 µL aliquots snap-frozen in liquid N2 and stored at -70°C. 
RPL Fusion Assay 
Fusion reactions were mixed in 20 µL volumes containing 400 µM Q-SNARE 
RPLs (based on lipid concentration) and 50 µM R-SNARE RPLs in RB150incubated at 
4°C overnight. Where Munc18 proteins were used, TEV protease was added in a 2:1 
molar ratio to ensure cleavage of the affinity tag in the reaction. Standard fusion reactions 
contained 2 µM Munc18a.  To prevent trans-SNARE complex formation, Q-RPLs were 
pre-incubated with 4 µM VAMP8CD for 1 hr at 4°C before addition of Munc18a and R-
RPLs. Reactions were added to 384 black Corning microplates and RPL fusion 
monitored at 37°C for dequenching of the NBD (λex= 460 nm, λem= 538 nm, λcutoff= 515 
nm) on R-SNARE RPLs. Fluorescence values are given as fold change from the initial 
fluorescence (Ft/F0). Where used, lipid mixing rate was determined by the 5-15 min 
slope.  
RPL Clustering Assay 
Standard fusion reactions, containing 4µM Munc18a, were diluted 40-fold in ice-
cold RB150. 4µL were placed on a microscope slide with a 22mm coverslip. A Zeiss 
confocal fluorescence microscope with a 63x objective was used to collect four images at 
random through Rhodamine fluorescence. Images were analyzed with ImageJ software 
(National Institute of Health) to determine the pixel size of particles after setting the 
lower threshold limit to 50 and upper threshold limit to 255, as previously described 
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(Hickey & Wickner, 2010). Pixel sizes were plotted on a probability graph using 
KaleidaGraph software. 
His6-tag Pulldown Assay 
A 20 nMol (2.5 µg) sample of His6-Munc18a was co-incubated with a 30 nMol of 
syntaxin incorporated into RPLs in a 30 µL volume overnight at 4°C. Samples were then 
co-incubated with 10 µL Ni-NTA resin (Qiagen) pre-equilibrated in binding buffer (20 
mM HEPES, pH 7.4, 150 mM NaCl, 10% Glycerol, and 20 mM Imidazole) in a 200 µL 
volume for 1hr at 4°C. Unbound protein was removed by collecting resin with 
centrifugation at 1000 × g for 1 min at 4°C, washing resin with 200 µL binding buffer 
three times. After washing bound proteins were solubilized with 20 µL SDS-PAGE 
sample buffer, boiled at 95°C for 5 min, loading 10 µL onto a 12% SDS-PAGE gel for 
analysis. 
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CHAPTER III  - RESULTS 
Mast cell SNAREs forms at least six fusogenic trans-SNARE complexes 
In a first step to investigate the mechanism of mast cell exocytosis, preliminary 
experiments were conducted to determine which combinations of the seven SNARE 
proteins implicated in degranulation formed fusogenic trans-SNARE complex. To this 
end, recombinant SNARE proteins (4 R-SNAREs, and 3 Q-SNAREs) were purified 
through affinity chromatography and incorporated into liposomes as shown in Figure 3A. 
R-SNAREs VAMP2, 3, 7, and 8 (lanes 1 to 4) were incorporated into donor liposomes in 
relatively equal amounts, whereas comparable levels of Q-SNAREs syntaxin3 and 
syntaxin4 were reconstituted along with SNAP-23 (lanes 5 to 6) into acceptor liposomes. 
Additionally, protein-free acceptor liposomes (lane 7) were reconstituted as negative 
controls for SNARE-mediated fusion. 
Resulting RPLs were assayed for lipid mixing through monitoring the FRET 
(fluorescence resonance energy transfer) between NBD-PE and Rhodamine-PE on the 
donor RPLs.  At high concentrations in the donor liposomes, the NBD fluorescence is 
quenched by the neighboring rhodamine.  However, as the result of lipid mixing with 
acceptor RPLs lacking bear rhodamine-PE or NBD-PE, this quenching effect becomes 
relieved via dilution, resulting in detectable increase of NBD signal.  
The eight possible combinations of mast cell SNAREs were assayed for lipid 
mixing (Figure 3B to 3E). Of these, six trans-SNARE complexes appear to be fusogenic: 
i) syntaxin3/SNAP-23/VAMP2, ii) syntaxin4/SNAP-23/VAMP2, iii) syntaxin3/SNAP-
23/VAMP3, iv) syntaxin4/SNAP-23/VAMP3, v) syntaxin3/SNAP-23/VAMP8, and vi) 
syntaxin4/SNAP-23/VAMP8 (Figure 3B, C and E). Reactions containing syntaxin4 
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and/or VAMP8 appear to be the most significant. In contrast, VAMP7 reactions (Figure 
3D) show similarity to reactions containing protein-free acceptor RPLs, indicating a lack 
of membrane fusion. 
 
Figure 3. SNARE-bearing RPLs implicated in mast cell exocytosis 
(A) Coomassie blue-stained SDS-PAGE gel showing incorporation of mast cell SNAREs into recovered liposomes. RPLs are loaded 
by calculating 20nmol total lipid. His6-TEV protease, used during reconstitution for affinity tag cleavage, is visible in small amounts 
in all RPLs (indicated by arrowhead). (B to E) Standard fusion reactions showing potential fusogenic SNARE complexes. 
Fluorescence of NBD on donor RPLs was monitored every minute for 2 hr. Data is represented as Ft/F0, Ft being fluorescence at a 
respective time point and F0 being initial fluorescence. Data represented by ‘x’ are control reactions with non-fusogenic protein-free 
acceptors (not readily visible in C and D). These results are representative of more than three biological replicates. 
Munc18a Selectively Stimulates Membrane Fusion 
 Mediated by Four SNARE-Complexes 
To clarify the role Munc18 isoforms play in mast cell degranulation, recombinant 
Munc18a, b and c were purified to test for any effect on each SNARE complex. After 
purification, affinity-tags at the N-terminus of Munc18 proteins were removed by TEV 
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protease during or prior to the RPL fusion reaction. Significant stimulation of fusion 
activity was observed when testing Munc18a in reactions containing R-SNAREs VAMP2 
(Figure 4, lanes 2 and 3) or VAMP3 (lanes 5 and 6) with either Q-SNARE acceptor 
RPLs. Replacing acceptor RPLs with protein-free liposomes showed no stimulation of 
fusion (lanes 1 and 4), indicating that the presence of SNARE proteins on apposing 
membranes is critical to Munc18a-dependent function. In contrast, reactions containing 
R-SNAREs VAMP7 (lanes 7-9) or VAMP8 (lanes 10-12) showed no significant change 
in activity with the addition of Munc18a. The specificity of Munc18a for VAMP2, but 
not VAMP8, has been observed during neurotransmission when VAMP2 residues were 
replaced with corresponding VAMP8 residues, resulting in diminished exocytosis in vivo 
(Shen et al., 2007). 
 
Figure 4. Munc18a selective stimulation of degranulation-relevant SNARE complexes. 
Liposomes bearing mast cell SNAREs were co-incubated overnight at 4°C with 2µM Munc18a or its control buffer, prior to 
fluorescence monitoring at 37°C. Lipid mixing was determined by the maximal rate of fluorescence increase from 5-20 minutes. Error 
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bars shown represent standard deviation and p-values determined through Student’s t-test (** indicates p<0.01). Results were 
compiled from three independent experiments. 
 
Figure 5. Munc18b/c exhibit no stimulation of mast cell SNARE complexes. 
Lipsomes bearing mast cell SNAREs were co-incubated overnight at 4°C with 2µM Munc18b, Munc18c or respective control buffers, 
prior to fluorescence monitoring at 37°C. Lipid mixing was determined by the maximal rate of fluorescence increase from 5-20 
minutes. Error bars shown represent standard deviation and p-values determined through Student’s t-test (* indicates p<0.05, ** 
indicates p<0.01). Results were compiled from three independent experiments. 
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Munc18b and Munc18c Do Not Stimulate Lipid Mixing Reactions 
In contrast to Munc18a, it seems that Munc18b and Munc18c are unable to 
stimulate fusion between mast cell SNARE-complexes (Figure 5). Pull-down assays with 
cognate syntaxins were performed to examine the possibility that recombinant Munc18b 
and Munc18c were expressed as misfolded, inactive proteins. Surprisingly, these results 
showed both these proteins as active in binding to their cognate SNAREs; Munc18b 
associated with both syntaxin3 and syntaxin4, while Munc18c showed a strong 
interaction with syntaxin4, but not syntaxin3 (Figure 6). These results show that these 
proteins remain biochemically active despite inability to promote membrane fusion. 
However, binary interaction between Munc18 and syntaxins can be viewed as Binding 
Mode 1, and not Binding Mode 2 which is responsible for fusion stimulation. 
The results of the pull-down assays (Figure 6) led us to question the syntaxin N-
terminal peptide on our recombinant protein. The N-terminal peptide in syntaxin plays an 
important role in Munc18-syntaxin Binding Mode 2, responsible for fusion enhancement. 
We wondered if the presence of an additional 4 amino acid residues at the N-terminus of 
recombinant syntaxin4 after affinity tag removal might have interfered with Munc18b 
and Munc18c’s stimulation of SNARE-mediated fusion. To examine this possibility, C-
terminally tagged Syntaxin4-MBP with a native N-terminus was incorporated into 
acceptor RPLs in place of the MBP-Syntaxin4 used in previous experiments. However, 
these data showed no difference from previous reactions shown in Figure 5 where no 
stimulation of fusion was seen (data not shown). Having tested the above mentioned 
possibilities, we propose that post-translational modifications to Munc18b and Munc18c 
 31 
may be critical to activate their pro-fusion function and enable Binding Mode 2 (see 
discussion). 
 
Figure 6. Recombinant Munc18b and Munc18c retain ability to bind syntaxin 
5µg His6-Munc18b or His6-Munc18c were pre-incubated with Ni-NTA resin prior to incubation with 2.5µg syntaxin-bearing RPLs 
overnight at 4°C. Resins were washed with RB150 thrice to remove unbound protein, then boiled in 2x Laemmli buffer before loading 
on an SDS-PAGE gel. 
Munc18a Selectively Promotes Liposome Clustering  
in an R-SNARE-Dependent Fashion 
Although Munc18a has been known tointeract with the trans-SNARE complex in 
neurotransmission (Shen et al., 2007), the exact roles of Munc18a in mast cell 
degranulation in unclear. To explore if Munc18a has an early role in the fusion cascade, 
we first examined Munc18a’s potential function in trans-SNARE complex formation (i.e. 
trans-SNARE zippering). To this end, mast cell R-SNAREs VAMP2 and VAMP8 were 
chosen for the study as they respond differently to Munc18a in lipid-mixing reactions. 
Syntaxin4/SNAP-23 acceptor RPLs are depicted as representatives for Q-SNAREs as 
similar results were obtained when syntaxin3/SNAP-23 RPLs were used. An observable 
feature of trans-SNARE zippering between apposing membranes would be clustering of 
RPLs, visible under confocal microscopy through excitation of rhodamine found on 
donor RPLs. A comparison of liposome size distribution would allow assessment of 
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clustering. The addition of Munc18a to syntaxin4/SNAP-23 + VAMP2 reactions (Figure 
7B) causes a noticeable increase in observed particle size, while reactions containing 
protein free acceptors (Figure 7A) or VAMP8-bearing donors (Figure 7C) were not 
influenced by Munc18a’s presence.  
 
Figure 7. Munc18a clusteres SNARE-bearing RPLs when VAMP2 is present 
Lipsomes were mixed according to standard fusion reaction conditions, with either 4µM Munc18a or buffer. After overnight 
incubation at 4°C samples were diluted 1:40 in RB150 before confocal microscopy. Four images were collected randomly from each 
sample and analyzed for accumulative distribution of particle sizes (A to C). Scale bars represent 20 µm. Images are representative of 
three experiments. 
Munc18a Relies on Syntaxin N-terminus for RPL Clustering 
Munc18 proteins function via interactions with their cognate SNAREs.  Our 
results indicate a clear R-SNARE specificity to Munc18a’s stimulation (Figure 4) and 
trans-SNARE zippering functions (Figure 7). However, while the importance of syntaxin 
N-terminal peptide has been noted in fusion (Shen, Rathore, Khandan, & Rothman, 
2010), it is unclear whether this plays a role in trans-SNARE zippering. To address this, 
recombinant syntaxin4∆N proteins were purified and incorporated into acceptor 
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liposomes along with His6-SNAP-23. Reactions with VAMP2 show syntaxin4∆N/SNAP-
23 maintains a similar pixel size distribution regardless of the presence of Munc18a 
(Figure 8B), indicating a clear necessity for this peptide in trans-SNARE complex 
formation. Furthermore, pulldown assays showed that His6-Munc18a failed to interact 
with both syntaxin3∆N and syntaxin4∆N, while full-length syntaxins were successfully 
detected (Figure 8A). Additionally, lipid-mixing assays with syntaxin4∆N failed to show 
Munc18a-dependent stimulation, in contrast to the wildtype syntaxin4 (Figure 8C). 
 
Figure 8. Syntaxin4 N-terminus required for Munc18a-mediated tethering 
Conditions for confocal microscopy are as previously described. A) His6-Munc18a pulldown of syntaxin RPLs. B) Accumulative 
distribution of particle sizes under confocal microscopy. Images are representative of three experiments. 
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Munc18a Facilities RPL Clustering through Binding Syntaxin and VAMP2 Prior to 
Trans-SNARE Complex Formation 
Having uncovered the biochemical requirement of cognate SNAREs in Munc18a 
tethering, we decided to further investigate whether Munc18a’s mechanism preluded 
trans-SNARE complex formation. Since Munc18a was previously shown to have no 
affinity for VAMP8 (Figure 4), soluble fragments of VAMP cytoplasmic domain 
(VAMPcd) were purified and co-incubated with syntaxin4/SNAP-23 liposomes to create 
an inert, tetrametric SNARE complex, incapable of fusion with VAMP2-bearing 
liposomes (as shown in Figure 9A). Blocking trans-SNARE complex formation between 
syntaxin4/SNAP-23 and VAMP2 would prevent RPL clustering, unless Munc18a could 
bind both simultaneously and hold them together. In fusion reactions, Munc18a-
dependent stimulation with VAMP2 RPLs is effectively inhibited when syntaxin4/SNAP-
23 RPLs are pre-blocked with VAMP8 cytoplasmic domain (VAMP8cd) (Figure 9B). In 
contrast, clustering of VAMP2 liposomes is still observed in the presence of Munc18a 
(Figure 9C). Unexpectedly, an identical effect is seen when VAMP2cd is used to block 
trans-SNARE complex formation; VAMP2 being a cognate SNARE of Munc18a. This 
indicates that Munc18a may have a preference for full-length, membrane-anchored 
VAMP2 over soluble cytoplasmic domains, possibly through altered conformation state, 
as previously suggested (Aran et al., 2009). Munc18a-dependent RPL clustering 
excluding membrane fusion indicates that Munc18a is able to bind the syntaxin N-
terminal peptide and VAMP2 without the formation of the trans-SNARE complex, as 
previously suggested (Yu et al., 2013). This is the strongest evidence to date that 
Munc18a aids tethering in a step distinct from trans-SNARE complex formation. 
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Figure 9. Soluble R-SNAREs prevent fusion but not Munc18a-mediated tethering 
Conditions for confocal microscopy are as previously described. A) Diagram of reaction procedure, B) Fusion assay showing 
VAMP8cd and VAMP2cd inhibition of Munc18a-dependent stimulation, C) Accumulative distribution of particle sizes under 
confocal microscopy. Images are representative of three experiments. 
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CHAPTER IV – DISCUSSION 
While Munc18 proteins play a vital role in regulating SNARE-mediated fusion in 
all eukaryotic cells, limited studies have been done in immune cells, particularly mast 
cells. Arguably, mast cells have enormous potential for thorough understanding of these 
proteins due to expression of all three mammalian isoforms and numerous exocytic 
SNAREs that serve as potential cognate receptors. In this study, it was found that 
Munc18a was the only isoform active in stimulating membrane fusion in mast cell 
SNAREs. Inquiries into its role in trans-SNARE zippering revealed a similar R-SNARE-
dependent selectivity that was seen in lipid mixing. Despite being R-SNARE-dependent, 
Munc18a-mediated trans-SNARE zippering was dependent on the N-terminal peptide 
from Q-SNARE syntaxin. Finally, our data suggests Munc18a facilitates RPL clustering 
through initiation of trans-SNARE complex formation, underpinning a new role for 
Munc18a in non-neuronal fusion events. 
The existence of numerous exocytic SNAREs in mast cells provides opportunity 
for multiple avenues for exocytosis. However, there have been major obstacles in the 
identification of functional SNARE complexes in mast cell degranulation. Although 
syntaxin4/SNAP-23/VAMP8 is considered to be the prime candidate for histamine 
release, syntaxin4 has also been seen to interact with VAMP2 and VAMP3 (Paumet et 
al., 2000). Syntaxin3 has only been seen to interact with VAMP7 (Puri, Kruhlak, 
Whiteheart, & Roche, 2003) and is speculated to regulate chemokine release in human 
mast cells (Frank, Thon, Bischoff, & Lorentz, 2011), possibly under the influence of 
Munc18b (Tadokoro et al., 2007). Our in vitro membrane fusion assay shows that all 
SNAREs except VAMP7 are capable of forming fusogenic complexes (Figure 3).  Why 
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certain complexes are favored above others in vivo requires further investigation, but our 
data begins to present a clearer understanding of SNARE-mediated exocytosis in mast 
cells. 
VAMP7 shows little activity in fusion assays (Figure 3D), although it may still 
have a role in mast cell exocytosis, as antibodies against VAMP7 reduced histamine 
release by 50% (Sander et al., 2008). VAMP7 is unique among VAMP isoforms as it 
contains an N-terminal self-inhibitory Longin domain that hinders its ability to enter a 
trans-SNARE complex. Phosphorylation of Y45 has been shown to relieve this inhibition 
in fibroblasts  (Burgo et al., 2013), though it is currently unknown if a similar mechanism 
is used in mast cells. Due to the native self-inhibiting conformation, a mutant ΔLongin-
VAMP7 could potentially be used to investigate the nature of VAMP7 in future in vitro 
fusion assays, although current efforts to purify the deletion mutant have not been 
successful (data not shown). 
Cell-based secretion studies have shown that Munc18a had a positive role in 
promoting mast cell β-hexosaminidase release (Bin et al., 2013). While VAMP8 remains 
the prime R-SNARE involved in β-hexosaminidase release (Paumet et al., 2000), our data 
shows that Munc18a is unable to stimulate VAMP8-containing complexes (Figure 4). 
Previous studies show that VAMP8-knockout mast cells have a severe deficiency in β-
hexosaminidase release, however, its inhibition is not complete (Puri & Roche, 2008; 
Tiwari et al., 2008). In the absence of VAMP8, an increasing amount of VAMP2 and 
VAMP3 were found associated with SNAP-23 (Tiwari et al., 2009), Taken together, I 
speculate that VAMP2 or VAMP3 play an supplemental role in β-hexosaminidase release 
in the event of compromised VAMP8. This release may be through a small, piecemeal 
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exocytosis rather than the dramatic degranulation typically observed. The observation 
that Munc18a regulates β-hexosaminidase release (Bin et al., 2013), but only has the 
capacity to regulate VAMP2 or VAMP3-based reactions warrants further investigation 
into these SNAREs as potential VAMP8-independent pathways for mast cell mediator 
release.  
The data shows that recombinant Munc18a is active in stimulating fusion (Figure 
4), whereas recombinant Munc18b and Munc18c do not share this activity (Figure 5). 
Despite the inability of Munc18b and Munc18c to stimulate fusion, they retain the ability 
to bind syntaxins (Figure 6), showing they remain in a biochemically active protein 
conformation. This may potentially indicate an important divergence in regulation of 
Munc18 protein function. It has been shown in numerous studies that phosphorylation 
can play an important role in modulating Munc18 activity inside the cell. 
Phosphorylation of Munc18a at Ser306 and Ser313 by PKC has been reported in chromaffin 
cells (Barclay et al., 2003; Fujita et al., 1996) and is critical to neurotransmission (Genç 
et al., 2014). Additionally, phosphorylation of Thr574 by CDK5 has also been reported in 
chromaffin cells to be essential for norepinephrine release (Fletcher et al., 1999). 
Similarly, it has been shown that Munc18b requires CDK5-dependent phosphorylation of 
Thr572 to promote assembly of syntaxin3/SNAP-25/VAMP8 complexes in gastric parietal 
cells in vivo (Liu et al., 2007). For Munc18c, phosphorylation of Y219 and Y521 by insulin 
receptor in adipose cells stimulates syntaxin4/SNAP-23/VAMP2 complexes critical for 
GLUT4 exocytosis (Aran et al., 2011; Jewell et al., 2011; Kioumourtzoglou, Gould, & 
Bryant, 2014), while native Munc18c inhibits fusion through binding of syntaxin4 
(Brandie et al., 2008). A possible explanation to the discrepancy between Munc18a, and 
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Munc18b and Munc18c, is that phosphorylation of Munc18b and Munc18c may be 
necessary to observe fusion stimulation, whereas Munc18a is active in its native form. 
This divergence between Munc18a, and Munc18b and Munc18c, could allow 
modification of exocytic activity in the absence of a phosphorylation cascade in vivo. 
This could avoid a complete shutdown of exocytosis in the cell. 
Munc18b has been regarded as the major regulator of mast cell degranulation. 
Whether or not Munc18b stimulates the same or different SNARE complexes as 
Munc18a remains to be determined, but VAMP8 is strongly indicated in vivo in other 
cell types(Al Hawas et al., 2012). CDK5-dependent phosphorylation of Munc18b, as 
observed in gastric parietal cells (Liu et al., 2007), is currently the best known 
mechanism for Munc18b activation. Further studies could utilize a phosphomimetic 
Munc18b T572D mutant to possibly observe stimulation of membrane fusion in 
reconstitution. 
Munc18c’s role in mast cells is completely unknown, with only a single study 
reporting that Munc18c overexpression did not affect phosphoserine externalization, a 
marker for degranulation (Martin-Verdeaux et al., 2003). Previous data suggests 
unphosphorylated Munc18c acts as a negative fusion regulator in translocation of 
GLUT4-containing vesicles  (Brandie et al., 2008). There are no identified kinases 
responsible for Munc18c phosphorylation in mast cells, which would be required to 
activate it. 
Previous in vitro data has shown Munc18a selectively stimulating 
syntaxin1/SNAP-25 fusion with VAMP2, 3 and 4, but not syntaxin4/SNAP-23 with 
VAMP2 or VAMP8 (Shen et al., 2007). In contrast, our data shows that Munc18a is able 
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to stimulate both syntaxin3 and syntaxin4-containing complexes (Figure 4), aligning with 
previous work stating that the N-terminal peptide of plasmalemmal syntaxins is not 
particularly selective (Hu et al., 2011). Additionally, recent data has shown Munc18c 
actively stimulating RPL fusion (Yu et al., 2013), whereas our data has shown no activity 
(Figure 5). However, Munc18c has been seen to play an inhibitory role in RPL fusion 
using SNAREs from GLUT4-vesicle translocation (syntaxin4, SNAP-23, and VAMP2) 
instead of negative (Brandie et al., 2008). The reason for these differences is unknown 
but could be related to the different protein expression and purification methods or 
differences in RPL lipid composition. Preliminary results indicate salt concentration in 
fusion reactions could play a role in determining Munc18c’s activity (data not shown). 
Munc18a’s ability to selectively promote RPL clustering (Figure 7) mirrors 
studies on related SM protein Vps33p, a subunit of the HOPS complex. HOPS plays a 
vital role in tethering membranes by binding regulatory lipids and membrane-associated 
Ypt7p (Hickey & Wickner, 2010). This tethering is independent of SNARE proteins, but 
by bringing apposing membranes into close proximity, it indirectly promotes trans-
SNARE complex formation. HOPS is also instrumental in protecting the preformed trans-
SNARE complex from disassembly via NSF and αSNAP (Xu, Jun, Thompson, Yates, & 
Wickner, 2010). Whether Munc18a fulfills the protective role in mast cell degranulation 
remains to be investigated. 
The requirement for syntaxin N-terminal peptide in conjunction with Munc18a in 
fusion has been reported but the precise role of this interaction is yet to be established  
(Munson & Bryant, 2009). Our data shows that Munc18a is unable to tether SNARE 
complexes or bind syntaxins in the absence of syntaxin N-terminal peptide (Figure 8). In 
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addition, both full-length syntaxin3 and syntaxin4 are capable of recruiting Munc18a, 
aligning with previous work stating that the N-terminal peptide of plasmalemmal 
syntaxins is not particularly selective (Hu et al., 2011; Shen et al., 2010). Showing that 
Munc18a tethers SNARE-bearing liposomes prior to trans-SNARE complex formation 
(Figure 9) reveals an important aspect of Munc18 proteins that has been overlooked. 
Whether this applies to other SM proteins will be an interesting topic of future research.   
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APPENDIX A – Mast cell mediators 
Table A1. Mast cell mediators 
Pre-stored Mediators Physiological Effect 
Biogenic amines 
 Histamine Vasodilation, angiogenesis, mitogenesis, pain 
 Serotonin Vasoconstriction, pain 
Chemokines 
 CXCL1a, IL-8 
(CXCL8), MCP-1 
(CCL2), MCP-3 
(CCL7), MCP-4, 
RANTES (CCL5), 
Eotaxin (CCL11) 
Chemoattraction and tissue infiltration of Leukocytes 
 
Enzymes 
 Arylsulfatases Lipid/Proteoglycan hydrolysis 
 Carboxypeptidase A Peptide Processing 
 Chymase (mMCP4) Tissue damage, pain, angiotensin II synthesis 
 Kinogenases Synthesis of vasodilatory kinins, pain 
 Phospholipases Arachidonic acid generation 
 Trypase (mMCP6) Tissue damage, activation of PAR, inflammation, pain 
 Matrix 
metalloproteinases Tissue damage, modification of cytokines/chemokines 
Peptides 
 Angiogenin Neovascularization 
 Corticotropin-
releasing hormone Inflammation, vasodilation 
 Endorphins Analgesia 
 Endothelin Sepsis 
 Kinins (bradykinin) Inflammation, pain, vasodilation 
 Leptin Food intake regulation 
 Renin Angiotensin synthesis 
 Somatostatin Anti-inflammatory (?) 
 Substance P Inflammation, pain 
 Urocortin Inflammation, vasodilation 
 VEGF Neovascularization, vasodilation 
 Vasoactive intestinal 
peptide Vasodilation, mast cell activation 
Proteoglycans 
 Chondroitin sulfate Cartilage synthesis, anti-inflammatory 
 Heparin Angiogenesis, nerve growth, factor stabilization 
 Hyaluronic acid Connective tissue, nerve growth, factor stabilization 
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Table A1 (continued). 
De Novo Synthesized Physiological Effect 
Cytokines 
 IL-1, 2, 3, 4, 5, 6, 
8b, 9, 10, 12a, 13, 
16, 18, 33a 
Inflammation, leukocyte migration, pain 
 IFNα, IFNβ, IGNγ, 
MIF, TGFβ, TNF-
αb, MIP-1α 
(CCL3), MIP-1β 
(CCL4)a 
Inflammation, leukocyte proliferation/activation 
Growth Factors 
 SCF, GM-CSF, β-
FGF, Neutrophin-3, 
NGF, PDGF, 
TGFβ, VEGF 
Growth of variety of cells 
Phospholipid Metabolites 
 Leukotriene B4 Leukocyte chemotaxis 
 Leukotriene C4 Vasoconstriction, pain 
 Platelet activating 
Factor Platelet activation, vasodilation 
 Prostaglandin D2 Bronchoconstriction, pain 
Others 
 Nitric Oxide Vasodilation 
Original table derived from (Theoharides et al., 2012) with minor modifications. a mediator not listed in original table, bmediators seen 
prestored and also newly synthesized. 
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